Zoetis is the world's largest animal health company, generating $9.3 billion in annual revenue as a Fortune 500 organization. With more than 70 years of operational history, the company discovers, develops, manufactures, and commercializes vaccines, medicines, diagnostics, and technologies for both companion animals and livestock across eight core species. Under CEO Kristin Peck, the U.S.-headquartered company operates globally, serving veterinarians, livestock producers, and the broader animal health ecosystem.
The company's technical domains span vaccinology, pharmaceutical development for animals, veterinary diagnostics, and disease prediction, prevention, detection, and treatment technologies. Zoetis maintains a Continuum of Care approach that integrates these capabilities across the animal health lifecycle. Its product portfolio addresses the full spectrum of animal health needs - from biological vaccines that prevent disease to pharmaceutical treatments, diagnostic tools for disease detection, and supporting technologies deployed across both companion animal and livestock applications. The company emphasizes applied animal health science and sustainability for livestock production systems.
For security professionals evaluating opportunities in the animal health sector, Zoetis represents a mature organization operating at significant scale in a heavily regulated industry. The company's global manufacturing and distribution operations, combined with its diagnostic and digital technology platforms, present a complex threat surface spanning pharmaceutical manufacturing systems, veterinary diagnostic infrastructure, supply chain operations, and customer-facing technology platforms serving millions of animal owners and agricultural producers worldwide.
